23 Active TrialsLarge Center
27 MS centers statewide · Ranked #1 in Florida for clinical trials
What kind of place is this?
Research FocusedComprehensive Care TeamPart of Major Health System
You’ll find an academic MS center where specialist care is paired with teaching and research. You can expect a specialist team and a broad view of inflammatory nervous system conditions. You may need to plan for in-person visits, since this is a statewide referral center based in Tampa.
Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services3/5
Clinical Trials & Research3/5
Insurance & Navigation Help1/5
Scheduling & Virtual Care2/5
About USF Multiple Sclerosis Center
This center combines MS specialty care with an academic medical environment and statewide referral reach. It also includes a formal fellowship program, which speaks to its training and teaching role within USF Health.
USF Multiple Sclerosis Center provides diagnosis and management for multiple sclerosis as well as other inflammatory conditions of the central nervous system, including optic neuritis, transverse myelitis, neuromyelitis optica spectrum disorder, and acute disseminated encephalomyelitis. The center serves as a statewide referral resource, which can be helpful if you need specialized MS expertise. Its academic setting connects you to USF Health, the Morsani College of Medicine, and Tampa General Hospital. The program is led by Dr. Derrick Robertson and includes clinicians, researchers, and educators working together.
Good to know
- Statewide referral center for MS and related inflammatory nervous system conditions
- Patients are also seen at Tampa General Hospital
- Led by Dr. Derrick Robertson, Director of the USF Multiple Sclerosis Division
- Offers a formal MS fellowship program
USF Multiple Sclerosis Center is an academic MS program in Tampa that treats multiple sclerosis and other central nervous system inflammatory diseases. It is part of USF Health and works closely with the USF Health Department of Neurology, the University of South Florida Morsani College of Medicine, and Tampa General Hospital. The center is led by Dr. Derrick Robertson, a neurologist and MS fellowship director. Patients can expect care from a team of experienced clinicians, researchers, and educators.
Featured Care Team Members
Derrick Robertson, MD
Professor and Vice Chair, Department of Neurology; Director, USF Multiple Sclerosis Division; Program Director, USF Multiple Sclerosis Fellowship; Associate Program Director, USF Neurology Residency
Neurology
Partnerships & Referral Network
- Tampa General Hospital (patients also seen there)
- USF Morsani College of Medicine
Services & Treatments
What They Treat
Multiple sclerosisOptic neuritisTransverse myelitisNeuromyelitis optica spectrum disorderAcute disseminated encephalomyelitisCentral nervous system inflammatory diseases
How They Treat It
Comprehensive care for patients with central nervous system inflammatory diseasesDiagnosis and management of multiple sclerosisDiagnosis and treatment of other CNS diseasesReferral-center care
Diagnostics
Diagnosis of multiple sclerosisDiagnosis of other CNS diseases
Research & Clinical Trials
This center is currently involved in 23 clinical trials — ranked #1 in Florida for active trials
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE4
OfatumumabDisease modifying treatment (DMT)
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
Ocrelizumab
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
Zenas BioPharma (USA), LLC
ACTIVE NOT RECRUITINGPHASE2
ObexelimabPlacebo
A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)
Hoffmann-La Roche
RECRUITINGPHASE2
Ocrelizumab Test FormulationOcrelizumab Reference Formulation
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
Ocrelizumab
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
OcrelizumabOcrelizumabAntihistamineMethylprednisolone
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
OcrelizumabOcrelizumabAntihistamineMethylprednisolone
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Celgene
RECRUITINGPHASE2
BMS-986368Placebo
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
Sanofi
ACTIVE NOT RECRUITINGPHASE3
TolebrutinibPlaceboTeriflunomide
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
Hoffmann-La Roche
RECRUITINGPHASE1
RO7121932 IVRO7121932 SC
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Novartis Pharmaceuticals
RECRUITINGPHASE3
Remibrutinib oral treatmentOcrelizumab
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
RemibrutinibTeriflunomide
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
OfatumumabTetanus toxoid (TT) containing vaccine (Td, Tdap)13-valent pneumococcal conjugate vaccine (13-PCV)23-valent pneumococcal polysaccharide vaccine (23-PPV)Seasonal Quadrivalent influenza vaccineKeyhole limpet hemocyanin (KLH) neo-antigen
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
Ofatumumab approved doseOfatumumab new dose
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
Sanofi
ACTIVE NOT RECRUITINGPHASE2
SAR441344 IVplacebo IVSAR441344 SCplacebo SCMRI contrast-enhancing preparations
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Reunion Neuroscience Inc
RECRUITINGPHASE2
RE104 for Injection
Study of COYA 302 for the Treatment of ALS
Coya Therapeutics
RECRUITINGPHASE2
COYA 302Placebo
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Celgene
RECRUITINGPHASE3
OzanimodFingolimodPlacebo
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibTeriflunomidePlacebo
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Johns Hopkins University
ACTIVE NOT RECRUITINGNA
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod
Insurance & Access
Contact
Carol and Frank Morsani Center for Advanced Healthcare, 13330 USF Laurel Drive, Tampa, FL 33612
Insurance & Support
Related MS Research
Recent studies relevant to this center's focus areas
FAQs from USF Multiple Sclerosis Center
The center treats multiple sclerosis and other central nervous system inflammatory diseases. Conditions include optic neuritis, transverse myelitis, neuromyelitis optica spectrum disorder, and acute disseminated encephalomyelitis.
Dr. Derrick Robertson leads the MS Division. He is a neurologist and serves as Professor and Vice Chair in the Department of Neurology, as well as Program Director for the USF Multiple Sclerosis Fellowship.
Yes. The center is affiliated with USF Health Department of Neurology, the University of South Florida Morsani College of Medicine, and Tampa General Hospital. Patients are also seen at Tampa General Hospital.
You can call (813) 821-8017 to arrange a visit. The center's focus is specialty MS and related neurological care, so calling the office is the best first step.
Compare Florida MS Centers
| Center | Type | Infusion | Virtual | Experience |
|---|---|---|---|---|
USF Multiple Sclerosis Center Tampa | Academic MS Center | — | — | 2.2/5 |
| Dedicated MS Practice | — | — | 3.4/5 | |
Memorial Regional Hospital MS Center Hollywood | Dedicated MS Practice | — | — | 3.4/5 |
| Community Hospital Program | — | — | 3.2/5 | |
| Regional Neurology Group | — | — | 3/5 | |
| Academic MS Center | — | — | 2.8/5 |
USF Multiple Sclerosis Center
Tampa • Academic MS Center
Infusion
—
Virtual
—
Experience
2.2/5
AdventHealth Center for Multiple Sclerosis and NeuroImmunology
Orlando • Dedicated MS Practice
Infusion
—
Virtual
—
Experience
3.4/5
Memorial Regional Hospital MS Center
Hollywood • Dedicated MS Practice
Infusion
—
Virtual
—
Experience
3.4/5
Baptist Health South Florida - MS & Neuroimmunology
Miami • Community Hospital Program
Infusion
—
Virtual
—
Experience
3.2/5
Multiple Sclerosis Care Center of Neurological Services Orlando
Orlando • Regional Neurology Group
Infusion
—
Virtual
—
Experience
3/5
University of Miami Multiple Sclerosis Center
Miami • Academic MS Center
Infusion
—
Virtual
—
Experience
2.8/5
MS Centers Across the U.S.
Click a state to browse its MS treatment centers.
Check out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
Information on this page is compiled from public sources including facility websites, ClinicalTrials.gov, CMS data, and AI analysis. It may not be complete or current. Always verify directly with the facility.